Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2025-12-25 @ 8:04 PM
Study NCT ID:
NCT00023335
Status:
COMPLETED
Last Update Posted:
2005-09-05
First Post:
2001-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
Sponsor:
Centers for Disease Control and Prevention
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1995-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2001-03
Completion Date Type:
None
First Submit Date:
2001-09-06
First Submit QC Date:
None
Study First Post Date:
2001-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2005-09-01
Last Update Post Date:
2005-09-05
Last Update Post Date Type:
ESTIMATED